Meiziya Kang L14 Capsules
Meiziya Kang L14 Capsules : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Tetrapanax papyriferus | Tetrapanax papyriferus[70 mg,450 mg] | Not identified |
| Codonopsis pilosula | Codonopsis pilosula[70 mg,450 mg] | Not identified |
| Liquidambar formosana | Liquidambar formosana[70 mg,450 mg] | Not identified |
| Paeonia lactiflora (Alba) | Paeonia lactiflora (Alba)[60 mg,450 mg] | Not identified |
| Bupleurum chinense | Bupleurum chinense[60 mg,450 mg] | Not identified |
| Rehmannia glutinosa | Rehmannia glutinosa[60 mg,450 mg] | Not identified |
| Ligusticum chuanxiong | Ligusticum chuanxiong[60 mg,450 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Product record
- Registration number
- MAL22066108TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- MEIZIYA INTERNATIONAL SDN. BHD.
- Manufacturer
- WAN YEEN TRADING SDN. BHD.
- Registration period starting
- 2022-06-20
- Published validity end
- 2027-06-20
Original register data
View published fields and their variants
- Active ingredients
- Tetrapanax papyriferus[70 mg,450 mg],Codonopsis pilosula[70 mg,450 mg],Liquidambar formosana[70 mg,450 mg],Paeonia lactiflora (Alba)[60 mg,450 mg],Bupleurum chinense[60 mg,450 mg],Rehmannia glutinosa[60 mg,450 mg],Ligusticum chuanxiong[60 mg,450 mg]
- Valid until
- 2027-06-20
- Registration date
- 2022-06-20
- Published description
- NATURAL PRODUCT
- Licence holder
- MEIZIYA INTERNATIONAL SDN. BHD.
- Producer
- WAN YEEN TRADING SDN. BHD.
- Published name
- Meiziya Kang L14 Capsules
- Published reference
- 202202106866T
- Registration number
- MAL22066108TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL22066108TC
Ministry of Health Malaysia / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Meiziya Kang L14 Capsules”, https://compoatlas.com/en/supplements/malaysia/MAL22066108TC-meiziya-kang-l14-capsules, updated 27 October 2026.